Activity of newer beta-lactam agents against clinical isolates of Bacteroides fragilis and other Bacteroides species.
AUTOR(ES)
O'Keefe, J P
RESUMO
The in vitro activities of beta-lactam antibiotics against Bacteroides fragilis and B. fragilis group isolates are presented. Clinical isolates from 1986 were compared with strains from 1979 to 1982. Imipenem, ticarcillin-clavulanic acid, and ceftizoxime were the most active agents. Cefotetan was equivalent to cefoxitin against B. fragilis but less active against B. fragilis group isolates. Enhancement of cefotaxime by its desacetyl metabolite was minimal.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=175843Documentos Relacionados
- Comparative activities of newer beta-lactam agents against members of the Bacteroides fragilis group.
- Comparison of the activities of penicillin G and new beta-lactam antibiotics against clinical isolates of Bacteroides species.
- Comparative antipseudomonal activity of some newer beta-lactam agents.
- In vitro activity of N-formimidoyl thienamycin, moxalactam, and other new beta-lactam agents against Bacteroides fragilis: contribution of beta-lactamase to resistance.
- Bactericidal activities of new beta-lactam antibiotics against Bacteroides fragilis.
